Prediction of Susceptibility to First-Line Tuberculosis Drugs by DNA Sequencing.
Allix-Béguec C
,
Arandjelovic I
,
Bi L
,
Beckert P
,
Bonnet M
,
Bradley P
,
Cabibbe AM
,
Cancino-Muñoz I
,
Caulfield MJ
,
Chaiprasert A
,
Cirillo DM
,
Clifton DA
,
Comas I
,
Crook DW
,
De Filippo MR
,
de Neeling H
,
Diel R
,
Drobniewski FA
,
Faksri K
,
Farhat MR
,
Fleming J
,
Fowler P
,
Fowler TA
,
Gao Q
,
Gardy J
,
Gascoyne-Binzi D
,
Gibertoni-Cruz AL
,
Gil-Brusola A
,
Golubchik T
,
Gonzalo X
,
Grandjean L
,
He G
,
Guthrie JL
,
Hoosdally S
,
Hunt M
,
Iqbal Z
,
Ismail N
,
Johnston J
,
Khanzada FM
,
Khor CC
,
Kohl TA
,
Kong C
,
Lipworth S
,
Liu Q
,
Maphalala G
,
Martinez E
,
Mathys V
,
Merker M
,
Miotto P
,
Mistry N
,
Moore DAJ
,
Murray M
,
Niemann S
,
Omar SV
,
Ong RT
,
Peto TEA
,
Posey JE
,
Prammananan T
,
Pym A
,
Rodrigues C
,
Rodrigues M
,
Rodwell T
,
Rossolini GM
,
Sánchez Padilla E
,
Schito M
,
Shen X
,
Shendure J
,
Sintchenko V
,
Sloutsky A
,
Smith EG
,
Snyder M
,
Soetaert K
,
Starks AM
,
Supply P
,
Suriyapol P
,
Tahseen S
,
Tang P
,
Teo YY
,
Thuong TNT
,
Thwaites G
,
Tortoli E
,
van Soolingen D
,
Walker AS
,
Walker TM
,
Wilcox M
,
Wilson DJ
,
Wyllie D
,
Yang Y
,
Zhang H
,
Zhao Y
,
Zhu B
.
N Engl J Med 2018 379 (15) 1403-1415